Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Outline
- Importance of India in global TB control
- 8.8 million incident cases of TB in 2010
- India accounted for 25% of this TB burden
- No country has more cases of TB than India
- TB control in India: what has been accomplished?
- TB control in India is the RNTCP responsibility
- RNTCP: achievements
- RNTCP has made the most of existing toolbox
- TB control in India has been cost-effective
- Challenges for TB control after DOTS scale-up
- Very slow decline in TB incidence
- What factors may explain this?
- Threat of drug-resistant TB
- What does "TDR-TB" really indicate?
- Mismanagement of TB in India
- RNTCP limited capacity to deal with MDR-TB
- TB diagnostic practices in the private sector
- WHO has warned against inaccurate TB tests
- Widespread use of serological tests for TB
- Survey: 17 of 22 use these antibody tests
- Why inaccurate TB tests used in India?
- Root causes for popularity of serology in India
- Government of India banned TB serology tests
- Treatment deviates from international standards
- TB drugs are very available
- Impact of TB mismanagement
- A typical TB patient in India
- New vision and goals for TB control
- What is the new vision for TB control?
- Raising the level of ambition: universal access
- The RNTCP will pursue the following approaches
- Universal access via improved, early diagnosis
- Media campaign
- Replacing bad with WHO-endorsed tests
- Engaging to replace serology with WHO-tools
- Improve notification of TB cases
- For the new vision to succeed, India needs
- How can India contribute to global TB control?
- India's economic growth
- India's progress in science
- India's progress in communications
- Success story with generic drugs and vaccines
- India is poised to take the lead in TB diagnostics
- Creating an ecosystem for innovation
- India can also provide leadership in research
- India's TB control will impact on global TB control
- BRICS are now poised to provide new leadership
- Thank you for listening
Topics Covered
- Importance of India in global TB control
- Burden of TB in India
- Challenges for TB control in India
- New vision and goals for TB control in India
- How can India contribute to global TB control?
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Pai, M. (2013, February 28). India: the epicentre of global TB control [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 30, 2024, from https://doi.org/10.69645/RWSA9166.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Madhukar Pai has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.